Health Care & Life Sciences » Medical Equipment & Supplies | Oculus Innovative Sciences Inc.

Oculus Innovative Sciences Inc. | Income Statement

Fiscal year is April-March. All values USD Thousands.
2014
2015
2016
2017
2018
Sales/Revenue
13,668.00
13,854.00
9,369.00
12,825.00
16,658.00
Cost of Goods Sold (COGS) incl. D&A
5,271.00
6,566.00
6,721.00
7,157.00
9,348.00
Gross Income
8,397.00
7,288.00
2,648.00
5,668.00
7,310.00
SG&A Expense
14,409.00
13,947.00
17,362.00
18,642.00
21,499.00
EBIT
6,012.00
6,659.00
-
12,974.00
14,189.00
Unusual Expense
10,924.00
1,486.00
11.00
-
-
Non Operating Income/Expense
120.00
56.00
20.00
18.00
357.00
Interest Expense
1,058.00
3.00
3.00
3.00
40.00
Pretax Income
3,735.00
8,203.00
14,724.00
12,937.00
14,328.00
Income Tax
-
-
-
4,268.00
-
Consolidated Net Income
3,735.00
8,203.00
14,724.00
8,669.00
14,328.00
Net Income
3,735.00
8,203.00
14,724.00
8,669.00
14,328.00
Net Income After Extraordinaries
3,735.00
8,203.00
19,286.00
26,612.00
14,328.00
Net Income Available to Common
3,735.00
8,203.00
10,162.00
10,405.00
14,328.00
EPS (Basic)
2.70
4.25
15.45
2.20
3.16
Basic Shares Outstanding
1,376.40
1,931.40
657.80
4,224.00
4,530.00
EPS (Diluted)
2.71
4.25
15.45
2.20
3.16
Diluted Shares Outstanding
1,379.60
1,931.40
657.80
4,224.00
4,530.00
EBITDA
5,728.00
6,406.00
14,470.00
12,726.00
13,699.00
Non-Operating Interest Income
1.00
1.00
2.00
22.00
258.00

About Oculus Innovative Sciences

View Profile
Address
1129 North McDowell Boulevard
Petaluma California 94954
United States
Employees -
Website http://www.sonomapharma.com
Updated 09/14/2018
Sonoma Pharmaceuticals, Inc. engages in identifying, developing, and commercializing therapies for chronic skin conditions. It offers solutions in dermatology, animal healthcare, and advanced tissue care product areas. Its products target skin diseases including acne, atopic dermatitis, scarring, infections, itch, pain, and harmful inflammatory responses.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.